日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Inhibition of ADAM9 promotes the selective degradation of KRAS and sensitizes pancreatic cancers to chemotherapy

抑制 ADAM9 可促进 KRAS 的选择性降解，使胰腺癌对化疗敏感

期刊:Nature Cancer
影响因子:23.5
doi:10.1038/s43018-023-00720-x
Yu-Kai Huang, Wei-Chung Cheng, Ting-Ting Kuo, Juan-Cheng Yang, Yang-Chang Wu, Heng-Hsiung Wu, Chia-Chien Lo, Chih-Ying Hsieh, Sze-Ching Wong, Chih-Hao Lu, Wan-Ling Wu, Shih-Jen Liu, Yi-Chuan Li, Ching-Chan Lin, Chia-Ning Shen, Mien-Chie Hung, Jaw-Town Lin, Chun-Chieh Yeh, Yuh-Pyng Sher
代谢
肿瘤
胰腺癌
发表日期：2024
文献求助 收藏

Glutathione S-transferase omega class 1 (GSTO1)-associated large extracellular vesicles are involved in tumor-associated macrophage-mediated cisplatin resistance in bladder cancer

谷胱甘肽 S 转移酶 omega 1 类 (GSTO1) 相关大型细胞外囊泡参与肿瘤相关巨噬细胞介导的膀胱癌顺铂耐药性

期刊:Molecular Oncology
影响因子:5
doi:10.1002/1878-0261.13659
Yi-Cheng Pan, Pei-Yi Chu, Ching-Chan Lin, Ching-Yun Hsieh, Wei-Yu Hsu, Lie-Fen Shyur, Juan-Cheng Yang, Wei-Chao Chang, Yang-Chang Wu
信号转导
肿瘤
膀胱癌
巨噬细胞
发表日期：2024
文献求助 收藏

ADAM9 drives the immunosuppressive microenvironment by cholesterol biosynthesis-mediated activation of IL6-STAT3 signaling for lung tumor progression

ADAM9通过胆固醇生物合成介导的IL6-STAT3信号通路激活，驱动免疫抑制性微环境，从而促进肺肿瘤进展。

期刊:American Journal of Cancer Research
影响因子:3.6
doi:10.62347/LODV2387
Jing-Pei Liu ，Kuan-Yin Shen ，Wei-Chung Cheng ，Wei-Chao Chang ，Chih-Ying Hsieh ，Chia-Chien Lo ，Ting-Ting Kuo ，Ching-Chan Lin ，Shih-Jen Liu ，Wen-Chin Huang ，Yuh-Pyng Sher
代谢
免疫/内分泌
信号转导
ADA
肿瘤免疫
IL6
JAK/STAT
肿瘤
STAT3
ADAM9
发表日期：2024
文献求助 收藏

Inhibition of CDCP1 by 8-isopentenylnaringenin synergizes with EGFR inhibitors in lung cancer treatment

8-异戊烯基柚皮素抑制 CDCP1 与 EGFR 抑制剂在肺癌治疗中产生协同作用

期刊:Molecular Oncology
影响因子:5
doi:10.1002/1878-0261.13429
Sze-Ching Wong, Chun-Chieh Yeh, Xun-Yu Zhang, Chih-Ying Hsieh, Chia-Chien Lo, Ting-Ting Kuo, Ching-Chan Lin, Chih-Hua Chao, Jing-Pei Liu, Ling-Chu Chang, Lu-Hai Wang, Yuh-Pyng Sher
肿瘤
肺癌
FCM
IF
IHC-P
WB
EGFR
发表日期：2023
文献求助 收藏

Macrophage secretory IL-1β promotes docetaxel resistance in head and neck squamous carcinoma via SOD2/CAT-ICAM1 signaling

巨噬细胞分泌 IL-1β 通过 SOD2/CAT-ICAM1 信号传导促进头颈部鳞状细胞癌对多西他赛产生耐药性

期刊:JCI Insight
影响因子:6.3
doi:10.1172/jci.insight.157285
Ching-Yun Hsieh, Ching-Chan Lin, Yu-Wen Huang, Jong-Hang Chen, Yung-An Tsou, Ling-Chu Chang, Chi-Chen Fan, Chen-Yuan Lin, Wei-Chao Chang
信号转导
肿瘤
头颈癌
巨噬细胞
发表日期：2022
文献求助 收藏

Combination of Durvalumab and Chemotherapy to Potentially Convert Unresectable Stage IV Penile Squamous Cell Carcinoma to Resectable Disease: A Case Report

度伐利尤单抗联合化疗有望将不可切除的IV期阴茎鳞状细胞癌转化为可切除的病例报告

期刊:Current Oncology
影响因子:3.4
doi:10.3390/curroncol30010026
Chen, Hao Xiang; Lin, Ching-Chan; Lin, Che-Hung; Yang, Chi-Rei
细胞生物学
肿瘤
肿瘤免疫
发表日期：2022
文献求助 收藏

ADAM9 promotes lung cancer progression through vascular remodeling by VEGFA, ANGPT2, and PLAT

ADAM9 通过 VEGFA、ANGPT2 和 PLAT 进行血管重塑，促进肺癌进展

期刊:Scientific Reports
影响因子:3.8
doi:10.1038/s41598-017-15159-1
Chen-Yuan Lin, Chia-Fong Cho, Shih-Ting Bai, Jing-Pei Liu, Ting-Ting Kuo, Li-Ju Wang, Yu-Sen Lin, Ching-Chan Lin, Liang-Chuan Lai, Tzu-Pin Lu, Chih-Ying Hsieh, Chin-Nan Chu, Da-Chuan Cheng, Yuh-Pyng Sher
肿瘤
肺癌
发表日期：2017
文献求助 收藏